🚀 VC round data is live in beta, check it out!
- Public Comps
- Jin Medical International
Jin Medical International Valuation Multiples
Discover revenue and EBITDA valuation multiples for Jin Medical International and similar public comparables like Prolight Diagnostics, Farmaceutica Remedia, Nortech Systems, iZafe Group and more.
Jin Medical International Overview
About Jin Medical International
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.
Founded
2020
HQ

Employees
295
Website
Sectors
Financials (FY)
EV
$12M
Jin Medical International Financials
Jin Medical International reported last fiscal year revenue of $21M and EBITDA of $959K.
In the same fiscal year, Jin Medical International generated $6M in gross profit, $959K in EBITDA, and $1M in net income.
Jin Medical International P&L
In the most recent fiscal year, Jin Medical International reported revenue of $21M and EBITDA of $959K.
Jin Medical International expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $21M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $6M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA | — | XXX | $959K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 3% | XXX | XXX | XXX |
| Net Profit | — | XXX | $1M | XXX | XXX | XXX |
| Net Margin | — | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $11M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Jin Medical International Stock Performance
Jin Medical International has current market cap of $23M, and enterprise value of $12M.
Market Cap Evolution
Jin Medical International's stock price is $0.14.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12M | $23M | 0.0% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJin Medical International Valuation Multiples
Jin Medical International trades at 0.6x EV/Revenue multiple, and 12.5x EV/EBITDA.
Jin Medical International Financial Valuation Multiples
As of March 28, 2026, Jin Medical International has market cap of $23M and EV of $12M.
Equity research analysts estimate Jin Medical International's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Jin Medical International has a P/E ratio of 19.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $23M | XXX | $23M | XXX | XXX | XXX |
| EV (current) | $12M | XXX | $12M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 12.5x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 19.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.0x | XXX | XXX | XXX |
| P/E | — | XXX | 19.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (3.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Jin Medical International Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Jin Medical International Margins & Growth Rates
Jin Medical International's revenue in the last fiscal year declined by (9%).
Jin Medical International Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (9%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (70%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Jin Medical International Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Prolight Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Nortech Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| iZafe Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Balsm Alofoq | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jin Medical International M&A Activity
Jin Medical International acquired XXX companies to date.
Last acquisition by Jin Medical International was on XXXXXXXX, XXXXX. Jin Medical International acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Jin Medical International
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialJin Medical International Investment Activity
Jin Medical International invested in XXX companies to date.
Jin Medical International made its latest investment on XXXXXXXX, XXXXX. Jin Medical International invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Jin Medical International
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Jin Medical International
| When was Jin Medical International founded? | Jin Medical International was founded in 2020. |
| Where is Jin Medical International headquartered? | Jin Medical International is headquartered in Japan. |
| How many employees does Jin Medical International have? | As of today, Jin Medical International has over 295 employees. |
| Who is the CEO of Jin Medical International? | Jin Medical International's CEO is Erqi Wang. |
| Is Jin Medical International publicly listed? | Yes, Jin Medical International is a public company listed on Nasdaq. |
| What is the stock symbol of Jin Medical International? | Jin Medical International trades under ZJYL ticker. |
| When did Jin Medical International go public? | Jin Medical International went public in 2023. |
| Who are competitors of Jin Medical International? | Jin Medical International main competitors are Prolight Diagnostics, Farmaceutica Remedia, Nortech Systems, iZafe Group. |
| What is the current market cap of Jin Medical International? | Jin Medical International's current market cap is $23M. |
| What is the current revenue of Jin Medical International? | Jin Medical International's last fiscal year revenue is $21M. |
| What is the current EV/Revenue multiple of Jin Medical International? | Current revenue multiple of Jin Medical International is 0.6x. |
| Is Jin Medical International profitable? | No, Jin Medical International is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.